The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry" - PubMed (original) (raw)
The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry"
Huanjie Yang et al. Mol Pharmacol. 2007 Feb.
Erratum in
- Correction to "The tumor proteasome is a primary target for the natural anticancer compound withaferin A isolated from 'Indian winter cherry'".
[No authors listed] [No authors listed] Mol Pharmacol. 2015 May;87(5):865. doi: 10.1124/mol.114.030015err. Mol Pharmacol. 2015. PMID: 25814535 Free PMC article. No abstract available.
Abstract
Withaferin A (WA) is a steroidal lactone purified from medicinal plant "Indian Winter Cherry" that is widely researched for its variety of properties, including antitumor effects. However, the primary molecular target of WA is unknown. By chemical structure analysis, we hypothesized that Withaferin A might be a natural proteasome inhibitor. Computational modeling studies consistently predict that C1 and C24 of WA are highly susceptible toward a nucleophilic attack by the hydroxyl group of N-terminal threonine of the proteasomal chymotrypsin subunit beta5. Furthermore, WA potently inhibits the chymotrypsin-like activity of a purified rabbit 20S proteasome (IC50=4.5 microM) and 26S proteasome in human prostate cancer cultures (at 5-10 microM) and xenografts (4-8 mg/kg/day). Inhibition of prostate tumor cellular proteasome activity in cultures and in vivo by WA results in accumulation of ubiquitinated proteins and three proteasome target proteins (Bax, p27, and IkappaB-alpha) accompanied by androgen receptor protein suppression (in androgen-dependent LNCaP cells) and apoptosis induction. Treatment of WA under conditions of the aromatic ketone reduction, or reduced form of Celastrol, had significantly decreased the proteasome-inhibitory and apoptosis-inducing activities. Treatment of human prostate PC-3 xenografts with WA for 24 days resulted in 70% inhibition of tumor growth in nude mice, associated with 56% inhibition of the tumor tissue proteasomal chymotrypsinlike activity. Our results demonstrate that the tumor proteasome beta5 subunit is the primary target of WA, and inhibition of the proteasomal chymotrypsin-like activity by WA in vivo is responsible for, or contributes to, the antitumor effect of this ancient medicinal compound.
Similar articles
- Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells.
Yang H, Landis-Piwowar KR, Lu D, Yuan P, Li L, Reddy GP, Yuan X, Dou QP. Yang H, et al. J Cell Biochem. 2008 Jan 1;103(1):234-44. doi: 10.1002/jcb.21399. J Cell Biochem. 2008. PMID: 17541980 - Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes.
Grover A, Shandilya A, Bisaria VS, Sundar D. Grover A, et al. BMC Genomics. 2010 Dec 2;11 Suppl 4(Suppl 4):S15. doi: 10.1186/1471-2164-11-S4-S15. BMC Genomics. 2010. PMID: 21143798 Free PMC article. - Metal complexes as inhibitors of the 26S proteasome in tumor cells.
Verani CN. Verani CN. J Inorg Biochem. 2012 Jan;106(1):59-67. doi: 10.1016/j.jinorgbio.2011.09.003. Epub 2011 Sep 10. J Inorg Biochem. 2012. PMID: 22112841 Review. - [Proteasome inhibitors: induction of apoptosis as new therapeutic option in prostate cancer].
Tahmatzopoulos A, Gudegast C, Stöckle M, Wullich B, Unteregger G, Zwergel U, Zwergel T. Tahmatzopoulos A, et al. Aktuelle Urol. 2004 Nov;35(6):491-6. doi: 10.1055/s-2004-830048. Aktuelle Urol. 2004. PMID: 15526229 Review. German.
Cited by
- Withania somnifera root extract inhibits fatty acid synthesis in prostate cancer cells.
Kim SH, Singh KB, Hahm ER, Lokeshwar BL, Singh SV. Kim SH, et al. J Tradit Complement Med. 2020 Feb 7;10(3):188-197. doi: 10.1016/j.jtcme.2020.02.002. eCollection 2020 May. J Tradit Complement Med. 2020. PMID: 32670813 Free PMC article. - Withaferin A suppresses skin tumor promotion by inhibiting proteasome-dependent isocitrate dehydrogenase 1 degradation.
Xu K, Zhang C, Li Y, Xi X, Zheng L, Meng M, Liu T, Zhao Y, Li W. Xu K, et al. Transl Cancer Res. 2019 Oct;8(6):2449-2460. doi: 10.21037/tcr.2019.09.57. Transl Cancer Res. 2019. PMID: 35116997 Free PMC article. - Biodiversity, Biochemical Profiling, and Pharmaco-Commercial Applications of Withania somnifera: A Review.
Gaurav H, Yadav D, Maurya A, Yadav H, Yadav R, Shukla AC, Sharma M, Gupta VK, Palazon J. Gaurav H, et al. Molecules. 2023 Jan 26;28(3):1208. doi: 10.3390/molecules28031208. Molecules. 2023. PMID: 36770874 Free PMC article. Review. - Withaferin A targets heat shock protein 90 in pancreatic cancer cells.
Yu Y, Hamza A, Zhang T, Gu M, Zou P, Newman B, Li Y, Gunatilaka AA, Zhan CG, Sun D. Yu Y, et al. Biochem Pharmacol. 2010 Feb 15;79(4):542-51. doi: 10.1016/j.bcp.2009.09.017. Biochem Pharmacol. 2010. PMID: 19769945 Free PMC article. - Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system.
Selvaraju K, Mofers A, Pellegrini P, Salomonsson J, Ahlner A, Morad V, Hillert EK, Espinosa B, Arnér ESJ, Jensen L, Malmström J, Turkina MV, D'Arcy P, Walters MA, Sunnerhagen M, Linder S. Selvaraju K, et al. Sci Rep. 2019 Jul 8;9(1):9841. doi: 10.1038/s41598-019-46168-x. Sci Rep. 2019. PMID: 31285509 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials